Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Future Healthcare of America (NTRU)
|
Add to portfolio |
|
|
|
| Price: |
$0.00
| | Metrics |
| OS: |
322.2
|
M
| |
|
|
| Market cap: |
|
| |
|
|
|
Net debt:
|
$488.1
|
k
| |
|
|
|
EV:
|
$488.4
|
k
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($8.0)
|
M
| |
|
|
|
EBIT
|
($8.5)
|
M
| |
|
|
| EPS |
($0.08)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 1.7 | 0.5 | 3.8 | 4.0 | 3.8 | 4.4 | 4.4 | 3.4 |
| Revenue growth | 218.3% | -86.3% | -4.1% | 4.9% | -13.6% | 0.9% | 27.9% | |
| Cost of goods sold | 1.1 | 0.4 | 2.9 | 2.7 | 2.8 | 3.8 | 3.7 | 2.9 |
| Gross profit | 0.6 | 0.1 | 0.9 | 1.3 | 1.0 | 0.6 | 0.6 | 0.6 |
| Gross margin | 37.1% | 17.8% | 23.4% | 31.7% | 25.9% | 13.2% | 14.7% | 16.6% |
| Selling, general and administrative | 5.9 | 7.3 | | | | 0.0 | | |
| Sales and marketing | | | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| General and administrative | 1.3 | 1.9 | 0.5 | 0.7 | 0.7 | 0.6 | 0.4 | 0.3 |
| EBIT | -5.6 | -7.4 | -0.4 | -0.2 | -0.5 | 0.2 | 0.2 | 0.2 |
| EBIT margin | -332.4% | -1407.1% | -10.2% | -4.0% | -11.9% | -2.6% | 4.5% | 5.5% |
| Pre-tax income | -5.7 | -7.7 | -0.3 | -0.2 | -1.1 | 0.0 | -0.9 | -0.5 |
| Income taxes | 1.3 | 1.4 | 0.0 | 0.0 | 0.5 | 0.0 | -0.3 | -0.6 |
| Tax rate | | | 0.0% | 0.0% | | 0.0% | 36.1% | 107.7% |
| Earnings from continuing ops | -5.7 | -7.7 | -0.3 | -0.2 | -1.6 | 0.1 | -0.6 | -0.3 |
| Earnings from discontinued ops | -1.3 | -1.4 | | | | | | |
| Net income | -7.0 | -9.1 | -0.3 | -0.2 | -1.6 | 0.1 | -0.6 | -0.3 |
| Net margin | -420.8% | -1738.4% | -7.4% | -6.2% | -40.9% | 2.1% | -13.2% | -10.1% |
| |
| Diluted EPS | ($0.05) | ($0.07) | ($0.03) | ($0.02) | ($0.15) | $0.01 | ($0.06) | ($0.03) |
| Shares outstanding (diluted) | 117.5 | 114.4 | 11.3 | 10.8 | 10.4 | 10.1 | 10.1 | 10.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|